At the same time as researchers look for biomarkers to predict ketamine reaction, clinicians locate on their own with a conundrum: Which patients ought to start with IV ketamine, and which with Spravato? And how do The 2 compare head to head in actual response to treatment? At present, the https://toril566esg3.wikiitemization.com/user